Hologic Inc. received FDA marketing clearance to use information from the Hologic Discovery Dual Energy X-ray Absorptiometry (DXA) system as a predictor of coronary heart disease, stroke and other forms of cardiovascular disease. The new indication, visualization of Abdominal Aortic Calcification (AAC), targets the No. 1 cause of morbidity and mortality in older women and men — heart disease and stroke.
Discovery measures the two primary diagnostic indicators of osteoporosis — bone mineral density and vertebral fractures. The FDA’s clearance, based on clinical data, means that doctors can use the information from a standard low dose, 10 second Instant Vertebral Assessment (IVA) osteoporosis test, to visualize the presence of AAC, which is associated with cardiovascular disease.


Related Content

News | Bone Densitometry Systems

Hologic Inc. announced it has signed an agreement with the University of Minnesota to be the exclusive provider of Dexalytics: TEAMS in North America. The partnership provides the sports science and human performance industry with a solution to harness body composition data obtained from dual X-ray absorptiometry (DXA) scans, compare it to sport- and position-specific standards, and provide actionable information that can help collegiate and professional trainers, coaches and medical staff train better athletes.

Time February 22, 2018
arrow
News | Bone Densitometry Systems

Teenagers who are obese may be doing irreparable damage to their bones, according to a new study being presented at the annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.

Time November 27, 2016
arrow
News | Clinical Trials

Teenagers who are obese may be doing irreparable damage to their bones, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA).

Time November 22, 2016
arrow
News | Radiology Imaging

Radiologic technologists and radiology departments looking to meet Joint Commission on Accreditation of Healthcare Organizations (JCAHO) safety requirements have a new series of online resources to help prepare for various examinations.

Time August 14, 2015
arrow
News

Hitachi Aloka Medical Ltd. announced the release of EggQus — a compact, portable ultrasound bone densitometry system — at the 2015 European Radiology Congress (ECR).

Time March 10, 2015
arrow
Technology

August 22, 2013 — Hologic Inc. announced the commercialization of Horizon, a redesigned DXA (dual-energy X-ray absorptiometry) imaging system for the assessment of three critical health problems — osteoporosis, cardiovascular disease and obesity.

Time August 22, 2013
arrow
Technology

In Sweden, 70,000 fractures are caused by osteoporosis every year. It is one of the most expensive diseases and is estimated to cost society about SEK 4.6 billion annually. Today, osteoporosis can be diagnosed using a simple Swedish method and treated with inexpensive and effective medication. If all women over the age of 65 were examined in conjunction with their mammography examination, the progression of the disease could essentially be stopped. This would also

Time December 20, 2012
arrow
Technology

June 15, 2012 — Lone Oak Medical Technologies announced that the U.S. Food and Drug Administration (FDA) has approved its AccuDXA2 bone mineral density assessment system for the U.S. market.

Time June 15, 2012
arrow
Technology

November 7, 2011 — Sectra Breast Imaging PACS (picture archiving and communication system) streamlines workflows of high-volume mammography screening and advanced diagnostic breast imaging procedures. It features true multimodality capabilities and now supports display and review of breast tomosynthesis images.

Time November 07, 2011
arrow
Technology

October 19, 2011 — At RSNA 2011, Sectra will launch its OneScreen system, an online solution to identify patients in the risk group for osteoporosis. The service is especially convenient in combination with mammography.

Time October 19, 2011
arrow
Subscribe Now